Skip to main content

Table 5 Incidence and clearance of anal HPV infections

From: The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature

Author (ref)

Population, age (yrs)

Incidence (per 100py)

Clearance

  

Any HPV

HR

16

18

Type of Infection

Unit of clearance

Any HPV

HR

16

18

Males

           

de Pokomandy [38]

HIV + ve MSM, 21–66

-

-

13.0

(9.6–17.6)

5.3

(3.5–8.0)

Prevalent

Per 100py

  

14.6

(10.2–21.2)

24.5

(16.9–35.4)

Nyitray [35]

MSM, 18–70

MSW, 18–70

31.1 (TS)

(16.6–53.2)

9.7

(7.2–12.8)

25.4

(14.5–41.2)

4.4

(2.9–6.6)

5.8

(1.9–13.4)

0.8

(0.2–2.0)

4.6

(1.2–11.6)

1.1

(0.4–2.3)

Prevalent

% at 6 m-

57.1 (TS)

(50.1–63.8)

70.9

(63.5–77.5)

55.8

(44.1–67.2)

77.5

(66.0–86.5)

27.2

(6.0–61.0)

100

(83.9–100)

62.5

(24.5–91.5)

100

(15.8–100)

Videla [23]

HIV + ve MSM, 20- > 69

HIV + ve MSW, 20- > 69

32.4 (NTS)

(23.3–43.7)

7.9

(4.9–15.7)

-

-

-

Prevalent

Per 100py

12.6 (NTS)

(10.2–15.2)

18.4

(12.2–26.5)

-

-

-

Darwich [20]

HIV + ve MSM, 20- > 69

HIV + ve MSW, 20- > 69

-

-

7.1

(5.5–9.5)

5.3

(3.0–8.6)

3.6

(3.5–5.2)

0.4

(0.1–1.8)

Prevalent

Per 100py

-

 

22.4

(17.6–28.1)

18.6

(7.4–38.2)

31.0

(20.3–45.4)

30.0

(7.8–76.8)

Mullins [37]

HIV-ve, 12–18

HIV + ve, 12–18

24 (NTS, first)

(11–52)

40

(27–61)

11

(3.4–33)

27

(17–44)

-

-

-

-

-

-

-

-

Glick [33]

MSM, 16–30

46.2 (NTS, unclear)

(45.6–46.9)

36.7

(36.2–37.3)

12.4

(12.1–12.6)

5.5

(5.3–5.6)

Prevalent

% at 1 year

81.3 (TS)

(67.4–91.1)

66.7

(49.0–81.4)

50.0

(26.0–74.0)

66.7

(22.3–95.7)

Hernandez [34]

HIV + ve MSM, mean 45

21.3 (TS, total)

(17.7–25.4)

13.3

(10.5–16.6)

3.5

(1.8–6.1)

3.7

(2.1–6.1)

-

-

-

-

-

-

Females

           

Goodman [36], Shvetsov [39]

Sexually active women, 18–44

56.3 (NTS, first)

(48.5–65.0)

23.4

(19.2–28.3)

3.0

(1.8–4.8)

2.3

(1.2–3.9)

Incident

Per 100py

89.3 (TS)

(67.8–115.4)

109.9

(83.3–142.4)

141.2

(73.0–246.7)

130.0

(47.6–282.8)

Moscicki [40]

Sexually active women, 13–21

-

-

-

-

Prevalent

% at 12 m

-

29.7 (TS 2 + neg)

(19.0–41.7)

45.0

(27.2–62.1)

55.6

(21.2–86.3)

Mullins [37]

HIV-ve women, 12–18

HIV + ve women, 12–18

14 (NTS,first)

(9.2–22)

30

(24–38)

5.3

(2.6–11)

12

(8.4–16)

-

-

-

-

-

-

-

-

  1. Abbreviations: MSM men who have sex with men, MSW men who have sex with women, py person-years, TS type-specific incidence defined as at least one positive test for any HPV type or HR-HPV type not detected at baseline, NTS non-type-specific incidence defined as at least one positive test for any HPV type or HR-HPV type among those negative for any HPV DNA or any HR-HPV DNA at baseline